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The growing burden of obesity has been referred to as an “epidemic”. The World Health 
Organisation estimates that 50% of adults living in Europe are overweight or obese 1, a 
population approximately equivalent to that of Germany, France, the United Kingdom and 
Italy together. This concerning statistic is made more terrifying by the data presented by 
Rosengren et al 2 in this issue of the European Heart Journal. They examined the association 
between body weight and the development of heart failure in over 1.5 million young men 
(mean age 18.6 years). They report that the incidence of heart failure in these young men, 
who had their body mass index (BMI) calculated as part of the physical examination for 
national service, was 5-7 per 100,000 person years of follow up in those of normal weight, 
rising to 12 to 40 per 100,000 person years of follow up in those who were overweight or 
obese as defined by their BMI. The risk of developing heart failure was 9 times higher in the 
highest BMI category (≥35 kg/m2) compared to those with normal BMI even after 
adjustment. Behind this relatively simple (and perhaps unsurprising) message lies a complex 
story that underscores the difficulty we have in dealing with the obesity epidemic.  
 
Compared to those who were normal weight, in those who were obese, the relative risk of 
developing heart failure was higher than the risk of experiencing a myocardial infarction 
(MI) or stroke. This suggests there may be a closer association between BMI and heart 
failure than either stroke or MI. Given that heart failure is commonly caused by ischaemic 
heart disease this finding is somewhat counterintuitive. We might expect BMI to be more 
strongly linked to the commonest precursor of heart failure, atherosclerotic heart disease, 
than heart failure itself. Obesity is associated with diabetes, high cholesterol and 
inflammation, all risk factors for the development of atherosclerosis. However, there is 
evidence linking obesity directly to heart failure. Obesity has a number of effects on the 
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cardiovascular system (Figure). Many of these are direct effects on the myocardium and are 
linked to the development of heart failure. Left ventricular mass and left atrial volume 
increase with increasing BMI, as does the degree of diastolic and systolic dysfunction 3 and 
ongoing myocardial injury may be detectable with newer high sensitivity troponin assays 4. 
Higher BMI is also associated with higher cardiac output, increased blood volume and 
alterations in pressure volume relationships in the heart that deal with these changes 5. 
Activation of various inflammatory pathways may explain some of the relationship between 
obesity and heart failure 6. Finally, cardiac steatosis is a recognised complication of obesity. 
Deposition of fat in the myocardium leads to progressive fibrosis further altering cardiac 
function 7. Contrast this to the associations between obesity and ischaemic heart disease 
which are less direct (Figure). Although not all atherosclerotic disease culminates in a 
myocardial infarction, autopsy findings of military personnel confirm that increasing BMI is 
associated with a greater burden of atherosclerosis 8. Therefore, despite the evidence 
linking obesity directly to the development of heart failure, could the association between 
obesity and heart failure simply be confounded by ischaemic heart disease? 
 
In the analysis by Rosengren et al 2, subgroup and secondary analyses were used to explore 
this issue. The association between BMI and heart failure was examined according to the 
aetiology of heart failure. The risk of heart failure with a secondary diagnosis of coronary 
heart disease, hypertension or diabetes mellitus was higher than the risk of heart failure 
without any of these diagnoses. For every one unit increase in BMI the risk of heart failure 
with coronary heart disease, diabetes or hypertension was 1.21 (95%CI 1.19- 1.22). 
Although this was stronger than the association between BMI and heart failure due to 
cardiomyopathy i.e. heart failure without an obvious aetiology (HR 1.11 95%CI 1.08-1.14) 
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the the population attributable fraction for obesity and heart failure due to cardiomyopathy 
was 15.4%, suggesting that the direct link between obesity and the development of heart 
failure is a substantial issue at a population level.  
 
However, we must be careful when trying to draw conclusions from these data, no matter 
how careful the analyses. The competing risk of death was not taken into account nor was 
the occurrence of MI or other risk factors for heart failure occurring in the intervening 
period. Other findings from the analyses also merit consideration when interpreting these 
data. The mean age at diagnosis of heart failure (which was defined as a hospitalisation for 
heart failure) was only 46 years. This may be a function of the length of follow up of this 
young cohort, but it is much younger than in other cohorts that report the mean age at 
diagnosis 9-11. Furthermore, the aetiology of heart failure in the young tends to be very 
different to the old 12. There were no data on other metrics of obesity such as waist and hip 
circumference. The distribution of body fat may be important in determining risk 13. This 
may be especially important in women whose body fat distribution is different to men. 
Similarly, there may be ethnic differences in body composition and the response to obesity 
that are important. Despite these limitations, how can we translate these epidemiological 
analyses into practice?  
 
Perhaps the most difficult and most important issue raised by the analyses is what is the 
ideal BMI? Although a number of interventions, at an individual and population level, are 
being explored as potential treatments for the obesity epidemic, what BMI should these 
interventions aim for? At a population level the answer would seem to be a BMI of less than 
22.5 kg/m2 in young men. Even a BMI in the range of 22.5 to <25 kg/m2, which is classed as 
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normal, was associated with a 58% higher risk of heart failure. Given that this group 
constituted nearly a quarter of the population studied, the absolute numbers of heart 
failure events in this group was one of the largest. The same was observed for MI (and to a 
lesser extent for stroke). The burden of heart failure, MI and stroke was greatest in the 
group with a BMI in the higher range of normal. Given these observations, should the 
“normal” range be redefined? Do BMI targets for weight loss interventions need to be 
lowered? Being underweight (BMI <18.5 kg/m2) was associated with a higher risk of events. 
Therefore, what happens to a person’s risk if they lose too much weight?  Without further 
studies, on more heterogeneous populations, who are more fully characterised (allowing for 
more complete multivariable adjustment of potential confounders), these questions remain 
difficult to answer.  
 
While Rosengren et al 2 have presented a salutary warning, as with all good research they 
raise more questions than they have answered. We must gain a better understanding of 
how the population level changes in the distribution of body mass are likely to influence 
rates of cardiovascular disease in the future. Otherwise we are in danger of finding 
ourselves dealing with both an obesity epidemic, and, the resurrection of epidemics of 
cardiovascular diseases that we had thought had begun to subside 9-11, 14.   
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Figure Legend 
Figure. Pathways linking obesity to the development of heart failure.  
